Precision Cancer Therapy
with Artificial Intelligence
Quark predicts drug response from genomic mutations using a 6.36B parameter transformer trained on 8× A100 GPUs — achieving 100% cancer type accuracy and 96.15% drug response accuracy. Paired with a deterministic physics engine, digital patient twins, and GPT-5.2 clinical reasoning.
Platform Capabilities
Digital Patient Twins
Comprehensive genomic, proteomic, and imaging integration for personalized treatment modeling.
GPT-Powered Reasoning
Advanced AI decision-making for therapy recommendations and treatment optimization.
3D Drug Simulation
Visualize and simulate chemotherapy treatments at molecular level before administration.
Physics Engine
Deterministic cancer spread modeling with conservation laws and temporal dynamics.
Medical Imaging
BiomedCLIP-powered pathology image classification and tissue analysis.
CRISPR Protocol Generator
AI-designed therapeutic gene editing protocols with Ensembl API gene lookup.
CAR-T Cell Designer
Multi-antigen targeting with AI-optimized immune cell engineering protocols.
Drug Interaction Checker
Real-time drug interaction analysis from clinical database for safe prescribing.
Analytics Dashboard
Patient cohort analytics with visualizations powered by real clinical data.
FDA Compliance
Regulatory tracking dashboard for clinical trial readiness and submission prep.
Lab Results
Laboratory test ordering, tracking, and result management with trend analysis.
Clinical Encounters
Patient encounter scheduling, documentation, and FHIR/DICOM-compliant records.